Sign Out
10 mg: Secondary amenorrhea, dysfunctional uterine bleeding due to hormonal imbalance in the absence of organic pathology, such as fibroids or uterine cancer, endometriosis.
100 mg: PROVERA tablets are indicated: As adjunctive and/or palliative treatment of recurrent and/or metastatic endometrial or renal carcinoma.
In the treatment of hormonally-dependent, recurrent breast cancer in post-menopausal women.
